Trial Profile
Effect of Vicriviroc on HIV RNA Levels in Cerebrospinal Fluid
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Vicriviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 16 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Feb 2009 Additional location Puerto Rico, USA identified as reported by ClinicalTrials.gov, last updated 22 Feb 2009